Skip to main content

Table 4 Cardiac remodeling in patients with and without right ventricular cardiac metastases

From: Risk stratification of cardiac metastases using late gadolinium enhancement cardiovascular magnetic resonance: prognostic impact of hypo-enhancement evidenced tumor avascularity

 

Right ventricular CMET+ (n = 41)

Other CMET+ (n = 71)*

p

Cardiac morphology

   

 Left ventricle

   

  Ejection fraction (%)

62 ± 8

64 ± 9

0.27

  Ejection fraction (< 50%)

10% (4)

9% (6)

1.00

  End-diastolic volume (mL)

110 ± 33

117 ± 35

0.27

  End-systolic volume (mL)

42 ± 17

42 ± 17

0.83

  Stroke volume (mL)

68 ± 21

75 ± 23

0.12

  Myocardial mass (gm)

130 ± 81

112 ± 37

0.19

 Right ventricle

   

  Ejection fraction (%)

52 ± 11

56 ± 8

0.048

  Ejection fraction (< 50%)

34% (14)

16% (11)

0.03

  End-diastolic volume (mL)

133 ± 41

129 ± 36

0.60

  End-systolic volume (mL)

65 ± 30

57 ± 20

0.11

  Stroke volume (mL)

68 ± 23

71 ± 23

0.54

 Atria

   

  Left atrial area (cm2)

18.2 ± 5.7

19.5 ± 5.1

0.25

  Right atrial area (cm2)

19.8 ± 6.7

18.7 ± 5.0

0.36

Lesion characteristics

   

 Anatomic properties

   

  Area (cm2)

9.5 ± 12.4

13.3 ± 19.7

0.27

  Perimeter (cm)

14.3 ± 14.0

13.6 ± 10.5

0.79

  Maximal Length (cm)

4.1 ± 2.7

4.6 ± 3.9

0.43

  Orthogonal Length (cm)

2.3 ± 1.5

2.9 ± 2.2

0.09

  Perimeter/Min Length

7.2 ± 8.3

5.6 ± 4.7

0.18

 Tissue properties

   

  Heterogenous Enhancement

49% (20)

55% (39)

0.53

  Contrast to Noise Ratio (CNR)

13.5 ± 14.8

14.8 ± 13.8

0.64

  Signal-to-Noise Ratio (SNR)

46.8 ± 46.9

33.5 ± 17.0

0.10

  Blood pool normalized

0.7 ± 0.3

0.6 ± 0.3

0.007

  1. * Inclusive of left ventricular, left atrial, and right atrial cardiac metastases